Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy
NCT01426464
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
22
Enrollment
INDIV
Sponsor class
Conditions
Glaucoma
Interventions
DRUG:
0.005% Latanoprost dosed once.
Sponsor
Nanduri, Padma, M.D., FACS